PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil. otavio.cmarques@usp.br.\', \'Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil. otavio.cmarques@usp.br.\', \'Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Sao Paulo, Brazil. otavio.cmarques@usp.br.\', \'Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Saint Petersburg State University, Saint-Petersburg, Russia.\', \'Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.\', \'Ariel University, Ariel, Israel.\', \'Department of Immunology, Immunosciences Laboratory, Inc., Los Angeles, CA, United States.\', \'Cyrex Laboratories, LLC 2602S. 24th St., Phoenix, AZ, 85034, USA.\', \'Department of Pediatrics, NYU Langone Medical Center, New York, NY, USA.\', \'Maimonides Medical Center, Brooklyn, NY, USA.\', \'Department of Biology, Yeshiva University, Manhatten, NY, USA.\', \'Department of Internal Medicine I, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.\', \'Department of Rheumatology, University Medical Center Schleswig-Holstein Campus Lübeck, Lübeck, Germany.\', \'Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.\', \'CellTrend Gesellschaft mit beschränkter Haftung (GmbH), Luckenwalde, Germany.\', \'Department of Pediatrics, University of Washington School of Medicine, and Seattle Children\'s Research Institute, Seattle, WA, USA.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.\', \'Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.\', \'Experimental and Clinical Research Center, a collaboration of Max Delbruck Center for Molecular Medicine and Charité Universitätsmedizin, and HELIOS Clinic, Department of Cardiology and Nephrology, Berlin, 13125, Germany.\', \'Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, UHN; Data Science Discovery Centre, Krembil Research Institute, UHN, Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, Canada.\', \'Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.\', \'School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.\', \'Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.\', \'Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.\', \'Department of Rheumatology, University Medical Center Schleswig-Holstein Campus Lübeck, Lübeck, Germany. gabriela.riemekasten@uksh.de.\', \'Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel. shoenfel@post.tau.ac.il.\', \'Saint Petersburg State University, Saint-Petersburg, Russia. shoenfel@post.tau.ac.il.\', \'Ariel University, Ariel, Israel. shoenfel@post.tau.ac.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-022-28905-5
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35264564
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all